126 related articles for article (PubMed ID: 37166494)
1. PET/MRI of hypoxia and vascular function in ER-positive breast cancer: correlations with immunohistochemistry.
Carmona-Bozo JC; Manavaki R; Miller JL; Brodie C; Caracò C; Woitek R; Baxter GC; Graves MJ; Fryer TD; Provenzano E; Gilbert FJ
Eur Radiol; 2023 Sep; 33(9):6168-6178. PubMed ID: 37166494
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia and perfusion in breast cancer: simultaneous assessment using PET/MR imaging.
Carmona-Bozo JC; Manavaki R; Woitek R; Torheim T; Baxter GC; Caracò C; Provenzano E; Graves MJ; Fryer TD; Patterson AJ; Gilbert FJ
Eur Radiol; 2021 Jan; 31(1):333-344. PubMed ID: 32725330
[TBL] [Abstract][Full Text] [Related]
3. 18F-fluoromisonidazole PET/CT: a potential tool for predicting primary endocrine therapy resistance in breast cancer.
Cheng J; Lei L; Xu J; Sun Y; Zhang Y; Wang X; Pan L; Shao Z; Zhang Y; Liu G
J Nucl Med; 2013 Mar; 54(3):333-40. PubMed ID: 23401605
[TBL] [Abstract][Full Text] [Related]
4. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
Kuijper A; van der Groep P; van der Wall E; van Diest PJ
Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1α expression in oral squamous cell carcinoma.
Sato J; Kitagawa Y; Yamazaki Y; Hata H; Okamoto S; Shiga T; Shindoh M; Kuge Y; Tamaki N
J Nucl Med; 2013 Jul; 54(7):1060-5. PubMed ID: 23699668
[TBL] [Abstract][Full Text] [Related]
6. Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas.
Kawai N; Lin W; Cao WD; Ogawa D; Miyake K; Haba R; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1870-8. PubMed ID: 24781871
[TBL] [Abstract][Full Text] [Related]
7. Comparison of DCE-MRI kinetic parameters and FMISO-PET uptake parameters in head and neck cancer patients.
Simoncic U; Leibfarth S; Welz S; Schwenzer N; Schmidt H; Reischl G; Pfannenberg C; Fougère C; Nikolaou K; Zips D; Thorwarth D
Med Phys; 2017 Jun; 44(6):2358-2368. PubMed ID: 28317128
[TBL] [Abstract][Full Text] [Related]
8. Monitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma.
Thézé B; Bernards N; Beynel A; Bouet S; Kuhnast B; Buvat I; Tavitian B; Boisgard R
BMC Cancer; 2015 Jul; 15():534. PubMed ID: 26198000
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.
Chen CL; Chu JS; Su WC; Huang SC; Lee WY
Virchows Arch; 2010 Jul; 457(1):53-61. PubMed ID: 20526721
[TBL] [Abstract][Full Text] [Related]
10.
Sato J; Kitagawa Y; Watanabe S; Asaka T; Ohga N; Hirata K; Okamoto S; Shiga T; Shindoh M; Kuge Y; Tamaki N
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):261-270. PubMed ID: 28734696
[TBL] [Abstract][Full Text] [Related]
11. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.
Tan EY; Yan M; Campo L; Han C; Takano E; Turley H; Candiloro I; Pezzella F; Gatter KC; Millar EK; O'Toole SA; McNeil CM; Crea P; Segara D; Sutherland RL; Harris AL; Fox SB
Br J Cancer; 2009 Jan; 100(2):405-11. PubMed ID: 19165203
[TBL] [Abstract][Full Text] [Related]
12. Correlation of quantitative parameters of magnetic resonance perfusion-weighted imaging with vascular endothelial growth factor, microvessel density and hypoxia-inducible factor-1α in nasopharyngeal carcinoma: Evaluation on radiosensitivity study.
Hu Y; E H; Yu X; Li F; Zeng L; Lu Q; Xi X; Shen L
Clin Otolaryngol; 2018 Apr; 43(2):425-433. PubMed ID: 28892580
[TBL] [Abstract][Full Text] [Related]
13. Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer.
Shan X; Wang D; Chen J; Xiao X; Jiang Y; Wang Y; Fan Y
J Comput Assist Tomogr; 2013; 37(1):22-8. PubMed ID: 23321829
[TBL] [Abstract][Full Text] [Related]
14. Correlation of (18)F-fluoromisonidazole PET findings with HIF-1α and p53 expressions in head and neck cancer: comparison with (18)F-FDG PET.
Norikane T; Yamamoto Y; Maeda Y; Kudomi N; Matsunaga T; Haba R; Iwasaki A; Hoshikawa H; Nishiyama Y
Nucl Med Commun; 2014 Jan; 35(1):30-5. PubMed ID: 24121312
[TBL] [Abstract][Full Text] [Related]
15. The Relationship Between the Tumor Cell Expression of Hypoxic Markers and Survival in Patients With ER-positive Invasive Ductal Breast Cancer.
Shamis SAK; Quinn J; Mallon EEA; Edwards J; McMillan DC
J Histochem Cytochem; 2022 Jul; 70(7):479-494. PubMed ID: 35792080
[TBL] [Abstract][Full Text] [Related]
16. [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis.
Bekaert L; Valable S; Lechapt-Zalcman E; Ponte K; Collet S; Constans JM; Levallet G; Bordji K; Petit E; Branger P; Emery E; Manrique A; Barré L; Bernaudin M; Guillamo JS
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1383-1392. PubMed ID: 28315948
[TBL] [Abstract][Full Text] [Related]
17. Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX.
Korkolopoulou P; Perdiki M; Thymara I; Boviatsis E; Agrogiannis G; Kotsiakis X; Angelidakis D; Rologis D; Diamantopoulou K; Thomas-Tsagli E; Kaklamanis L; Gatter K; Patsouris E
Hum Pathol; 2007 Apr; 38(4):629-38. PubMed ID: 17367605
[TBL] [Abstract][Full Text] [Related]
18. Dual-Tracer Assessment of Dynamic Changes in Reoxygenation and Proliferation Decrease During Fractionated Radiotherapy in Murine Tumors.
Yu W; Su X; Zhang D; Qiao F; Wang H; Jiang J; Xu H
Front Oncol; 2020; 10():1046. PubMed ID: 32766135
[No Abstract] [Full Text] [Related]
19. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer.
Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield S; Bersiga A; Allevi G; Milani M; Aguggini S; Gandolfi V; Dogliotti L; Bottini A; Harris AL; Fox SB
Clin Cancer Res; 2006 Aug; 12(15):4562-8. PubMed ID: 16899602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
